Multienzyme Active Manganese Oxide Alleviates Acute Liver Injury by Mimicking Redox Regulatory System and Inhibiting Ferroptosis
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202302556 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Aimin Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu, 611130, China. Hauptthemen laut MEDLINE: Manganese Compounds, Ferroptosis, Oxides, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Drug‐induced liver injury (DILI) is a severe condition characterized by impaired liver function and the excessive activation of ferroptosis. Unfortunately, there are limited options currently available for preventing or treating DILI. In this study, MnO 2 nanoflowers (MnO 2 Nfs) with remarkable capabilities of mimicking essential antioxidant enzymes, including catalase, superoxide dismutase (SOD), and glutathione peroxidase are successfully synthesized, and SOD is the dominant enzyme among them by density functional theory. Notably, MnO 2 Nfs demonstrate high efficiency in effectively eliminating diverse reactive oxygen species (ROS) such as hydrogen peroxide (H 2 O 2 ), superoxide anion (O 2 •− ), and hydroxyl radical (•OH). Through in vitro experiments, it is demonstrated that MnO 2 Nfs significantly enhance the recovery of intracellular glutathione content, acting as a potent inhibitor of ferroptosis even in the presence of ferroptosis activators. Moreover, MnO 2 Nfs exhibit excellent liver accumulation properties, providing robust protection against oxidative damage. Specifically, they attenuate acetaminophen‐induced ferroptosis by inhibiting ferritinophagy and activating the P62‐NRF2‐GPX4 antioxidation signaling pathways. These findings highlight the remarkable ROS scavenging ability of MnO 2 Nfs and hold great promise as an innovative and potential clinical therapy for DILI and other ROS‐related liver diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu, 611130, China.
- College of Science, Sichuan Agricultural University, Chengdu, Sichuan, 611130, China.
- College of Agronomy, Sichuan Agricultural University, Chengdu, Sichuan, 611130, China.
- College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan, 611130, China.
ORCID-Profile: Xianxiang Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wu, A., Li, M., Chen, Y., Zhang, W., Li, H., Chen, J., Gu, K., & Wang, X. (2024). Multienzyme Active Manganese Oxide Alleviates Acute Liver Injury by Mimicking Redox Regulatory System and Inhibiting Ferroptosis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202302556
Vancouver
Wu A, Li M, Chen Y, Zhang W, Li H, Chen J, et al. Multienzyme Active Manganese Oxide Alleviates Acute Liver Injury by Mimicking Redox Regulatory System and Inhibiting Ferroptosis. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202302556
BibTeX
@article{Wu2024,
author = {Wu, Aimin and Li, Min and Chen, Yinyin and Zhang, Wei and Li, Haoran and Chen, Junzhou and Gu, Ke and Wang, Xianxiang},
title = {Multienzyme Active Manganese Oxide Alleviates Acute Liver Injury by Mimicking Redox Regulatory System and Inhibiting Ferroptosis},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202302556}
}
EUVIMED